3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia
2
Hepatoblastoma
2
Glioblastoma
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uveal Melanoma
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Ototoxicity
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Cyclophosphamide
7
Etoposide
5
Prednisone
4
Doxorubicin
4
Vincristine
3
romidepsin
2
pembrolizumab
2
etoposide phosphate
2
duvelisib
2
Melphalan
2
Brentuximab Vedotin
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
sodium-iodide symporter
1
ruxolitinib
1
prednylidene
1
glofitamab
1
fludarabine phosphate
1
fludarabine
1
deltacortene
1
cemiplimab
1
brincidofovir
1
belinostat
1
X-Rays
1
Whole-Body Irradiation
1
Valganciclovir
1
Therapeutics
1
Tacrolimus
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Vorinostat
×
1 year
×
Clear all
No trials found.